Sima Patel, DO
Allergy · New York, NYNPI 1912263450
Payments from drug & device makers
Across 822 payments — averaging $25.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Sanofi$4K
- GSK$3K
- Kaleo, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Novartis$868
- plus $6K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 188 | $5,254 |
| Sanofi | 110 | $3,727 |
| GSK | 168 | $3,461 |
| Kaleo, Inc. | 54 | $1,051 |
| Regeneron Healthcare Solutions, Inc. | 39 | $1,014 |
| Novartis | 43 | $868 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $746 |
| Pfizer | 27 | $589 |
| Amgen(2 entities) | 24 | $498 |
| Teva Pharmaceuticals USA, Inc. | 22 | $468 |
| CSL Behring | 13 | $430 |
| Blueprint Medicines Corporation | 9 | $399 |
| Genentech USA, Inc. | 23 | $388 |
| LEO Pharma Inc. | 9 | $360 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $257 |
| Optinose US, Inc. | 15 | $236 |
| Biocryst US Sales Co., LLC | 9 | $208 |
| Galderma Laboratories, L.p. | 9 | $166 |
| Pharming Healthcare, Inc. | 6 | $148 |
| Stryker | 1 | $132 |
| Lilly USA, LLC | 2 | $117 |
| Hikma Pharmaceuticals USA | 7 | $114 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Alk-abello, Inc | 3 | $91 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| AbbVie | 2 | $51 |
| Boehringer Ingelheim | 1 | $31 |
| Cycle Pharmaceuticals Inc | 1 | $28 |
| Grifols USA, LLC | 1 | $25 |
| Insulet Corporation | 1 | $24 |
| Incyte Corporation | 1 | $21 |
| Covis Pharma GmbH | 1 | $21 |
| Phadia US Inc. | 1 | $17 |
| Merck | 1 | $13 |
| Organon | 1 | $5 |
How this compares
$21,113 in reported general payments places this provider in the 80th percentile of 92 allergy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in New York
- Rachel MillerNew York$56K
- Mariana MarcuNew York$43K
- Gillian ShepherdNew York$7K
- Anna KochinNew York$7K
- Wellington TichenorNew York$6K
- Rushita MehtaNew York$694
- Lisa Ellman-GruntherNew York$627
- Christopher SmithHorseheads$18M
- Marc BraunsteinHewlett$924K
- Allison RamseyRochester$904K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.